Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
This group also includes newer indication-specific treatments such as elamipretide, which received accelerated FDA approval in 2025 to improve muscle strength in adults and children with Barth syndrome
Multiple Sclerosis Trial A separate investigation explored this compound in the context of multiple sclerosis, likely motivated by the compounds documented interactions with the dopaminergic and neuroprotective systems identified in animal research
Read the warnings before purchase
A state-licensed, board-certified MD, DO, or qualified medical provider reviews your intake and creates a treatment plan personalized for you.* Enjoy 24/7 direct access to a provider, plus community support and motivation to keep you on track
US$ 24.78
US$ 23.94
US$ 27.42
US$ 22.93
US$ 27.92
